CSLD2 is a member of the Cellulose Synthase-Like D (CSLD) family in Arabidopsis, functioning as a mannan synthase critical for cell wall biosynthesis during plant development. It operates cooperatively with CSLD3 and CSLD5, forming heteromeric complexes essential for synthesizing cell wall polysaccharides required for cytokinesis and root hair elongation .
CSLD2 interacts directly with CSLD3 and CSLD5, as shown by bimolecular fluorescence complementation assays. These interactions suggest a functional complex critical for mannan synthesis. Additionally, CSLD2 is regulated by the anaphase-promoting complex (APC) activator CCS52A2, which mediates its ubiquitination and degradation during cell cycle progression .
Key Findings:
CSLD2 activity is interdependent with CSLD3 and CSLD5 for cell plate formation during mitosis .
Yeast two-hybrid assays confirm direct interaction between CSLD2 and CCS52A2, linking its turnover to cell cycle regulation .
CSLD2 lacks G2/M-phase-specific transcriptional regulation, unlike CSLD5, indicating functional divergence .
While no studies explicitly describe the development or validation of a CSLD2-specific antibody, inferred applications include:
Localization Studies: Tracking CSLD2 during cell plate formation using fluorescent tagging (e.g., Cerulean-CSLD2 fusions) .
Protein Turnover Analysis: Immunoprecipitation with anti-ubiquitin antibodies to study APC-mediated degradation .
Mutant Phenotyping: Western blotting to quantify CSLD2 levels in csld mutants .
Antibody Validation: No peer-reviewed publications yet detail CSLD2 antibody specificity or epitope mapping.
Functional Redundancy: Overlapping roles of CSLD2 with CSLD3/CSLD5 complicate isolation of its unique contributions .
Evolutionary Conservation: CRISPR/Cas9 editing of SoCSLD2 in spinach highlights conserved roles in root hair development, suggesting cross-species antibody utility .
Based on the provided search results and absence of direct references to "CSLD2 Antibody" in the literature corpus, this term appears to be either a typographical error or a highly specialized/non-canonical designation not represented in current antibody research databases. Below is an analytical framework for addressing such terminology gaps in antibody research:
How to design experiments for uncharacterized antibody targets?
Stepwise approach:
Epitope characterization:
Functional validation:
| Assay Type | Purpose | Validation Controls |
|---|---|---|
| Surface plasmon resonance (SPR) | Binding kinetics | Known antigen-antibody pairs |
| Flow cytometry | Cellular localization | Isotype-matched antibodies |
| Immunoprecipitation | Complex identification | Knockout cell lines |
How to address conflicting data in antibody specificity studies?
What experimental factors affect antibody reproducibility?